Increased complement C1q level marks active disease in human tuberculosis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Cai, Yi ^a,b   Yang, Qianting ^b   Tang, Yueqiang ^b   Zhang, Mingxia ^b   Liu, Haiying ^c   Zhang, Guoliang ^b   Deng, Qunyi ^b   Huang, Jian ^b,d   Gao, Zhiliang ^a   Zhou, Boping ^b   Feng, Carl G ^e   Chen, Xinchun ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^c INSTITUTE OF PATHOGEN BIOLOGY   (China)

^d National Engineering Center for Biochip at Shanghai   (China)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; COMPLEMENT COMPONENT C1Q; INTERLEUKIN 6; MESSENGER RNA; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLEURA EFFUSION; PLEURISY; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOUS PLEURISY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; COMPLEMENT C1Q; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TUBERCULOSIS; YOUNG ADULT;

EID: 84898636026     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092340     Document Type: Article

References (47)

1. World Health Organization (2013) Global tuberculosis control.
2. Tuberculosis, (2011) NICE Clinical Guideline.
3. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, et al. (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271: 698-702. (Pubitemid 24061706)
4. Dorman SE (2010) New diagnostic tests for tuberculosis: bench, bedside, and beyond. Clin Infect Dis 50 Suppl 3: S173-177.
5. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, et al. (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357: 2017-2021. (Pubitemid 32592390)
6. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, et al. (2004) Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170: 59-64. (Pubitemid 38997752)
7. Losi M, Bossink A, Codecasa L, Jafari C, Ernst M, et al. (2007) Use of a T-cell interferon-gamma release assay for the diagnosis of tuberculous pleurisy. Eur Respir J 30: 1173-1179. (Pubitemid 351194766)
8. Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, et al. (2011) Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 204 Suppl 4: S1120-1129.
9. Chen X, Yang Q, Zhang M, Graner M, Zhu X, et al. (2009) Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol 16: 879-884.
10. Denkinger CM, Dheda K, Pai M (2011) Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 17: 806-814.
11. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, et al. (2007) Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 45: 837-845. (Pubitemid 47580374)
12. Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, et al. (2009) Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis 9: 162-172.
13. Benoit ME, Clarke EV, Morgado P, Fraser DA, Tenner AJ (2012) Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells. J Immunol 188: 5682-5693.
14. Nayak A, Pednekar L, Reid KB, Kishore U (2012) Complement and non-complement activating functions of C1q: a prototypical innate immune molecule. Innate Immun 18: 350-363.
15. Bohlson SS, Fraser DA, Tenner AJ (2007) Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions. Mol Immunol 44: 33-43. (Pubitemid 44647109)
16. Schorey JS, Carroll MC, Brown EJ (1997) A macrophage invasion mechanism of pathogenic mycobacteria. Science 277: 1091-1093. (Pubitemid 27371629)
17. Cortes-Hernandez J, Fossati-Jimack L, Petry F, Loos M, Izui S, et al. (2004) Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice. Eur J Immunol 34: 3713-3722. (Pubitemid 40012189)
18. Petry F, Botto M, Holtappels R, Walport MJ, Loos M (2001) Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells. J Immunol 167: 4033-4037. (Pubitemid 32910849)
19. Chen G, Tan CS, Teh BK, Lu J (2011) Molecular mechanisms for synchronized transcription of three complement C1q subunit genes in dendritic cells and macrophages. J Biol Chem 286: 34941-34950.
20. Korotzer AR, Watt J, Cribbs D, Tenner AJ, Burdick D, et al. (1995) Cultured rat microglia express C1q and receptor for C1q: implications for amyloid effects on microglia. Exp Neurol 134: 214-221.
21. Maeda M, Muro H, Shirasawa H (1988) C1q production and C1q-mediated immune complex retention in lymphoid follicles of rat spleen. Cell Tissue Res 254: 543-551.
22. Lu J, Teh BK, Wang L, Wang Y, Tan YS, et al. (2008) The classical and regulatory functions of C1q in immunity and autoimmunity. Cellular & Molecular Immunology 5: 9-21.
23. Reid KB (1986) Activation and control of the complement system. Essays Biochem 22: 27-68.
24. Fraser DA, Bohlson SS, Jasinskiene N, Rawal N, Palmarini G, et al. (2006) C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol 80: 107-116. (Pubitemid 44835531)
25. Chen A, Gaddipati S, Hong Y, Volkman DJ, Peerschke EI, et al. (1994) Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J Immunol 153: 1430-1440. (Pubitemid 24251088)
26. Castellano G, Woltman AM, Schlagwein N, Xu W, Schena FP, et al. (2007) Immune modulation of human dendritic cells by complement. Eur J Immunol 37: 2803-2811. (Pubitemid 47578300)
27. Heeger PS, Kemper C (2012) Novel roles of complement in T effector cell regulation. Immunobiology 217: 216-224.
28. Son M, Santiago-Schwarz F, Al-Abed Y, Diamond B (2012) C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proc Natl Acad Sci U S A 109: E3160-3167.
29. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2011) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12: 15-22.
30. Chen X, Zhou B, Li M, Deng Q, Wu X, et al. (2007) CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123: 50-59. (Pubitemid 46420558)
31. Eum SY, Kong JH, Hong MS, Lee YJ, Kim JH, et al. (2010) Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137: 122-128.
32. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
33. Qiu Z, Zhang M, Zhu Y, Zheng F, Lu P, et al. (2012) Multifunctional CD4 T cell responses in patients with active tuberculosis. Sci Rep 2: 216.
34. Yu Y, Zhang Y, Hu S, Jin D, Chen X, et al. (2012) Different patterns of cytokines and chemokines combined with IFN-gamma production reflect Mycobacterium tuberculosis infection and disease. PLoS One 7: e44944.
35. El-Sony A, Enarson D, Khamis A, Baraka O, Bjune G (2002) Relation of grading of sputum smears with clinical features of tuberculosis patients in routine practice in Sudan. Int J Tuberc Lung Dis 6: 91-97. (Pubitemid 34263698)
36. Ors F, Deniz O, Bozlar U, Gumus S, Tasar M, et al. (2007) High-resolution CT findings in patients with pulmonary tuberculosis: correlation with the degree of smear positivity. J Thorac Imaging 22: 154-159. (Pubitemid 46868286)
37. Liang QL, Shi HZ, Wang K, Qin SM, Qin XJ (2008) Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 102: 744-754.
38. Cliff JM, Lee JS, Constantinou N, Cho JE, Clark TG, et al. (2013) Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 207: 18-29.
39. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A (2011) Immunological biomarkers of tuberculosis. Nat Rev Immunol 11: 343-354.
40. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
41. Castano D, Garcia LF, Rojas M (2011) Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 91: 348-360.
42. Farber K, Cheung G, Mitchell D, Wallis R, Weihe E, et al. (2009) C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. J Neurosci Res 87: 644-652.
43. Abebe M, Kim L, Rook G, Aseffa A, Wassie L, et al. (2011) Modulation of cell death by M. tuberculosis as a strategy for pathogen survival. Clin Dev Immunol 2011: 678570.
44. Cambier CJ, Takaki KK, Larson RP, Hernandez RE, Tobin DM, et al. (2014) Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 505: 218-222.
45. Antonelli LR, Gigliotti Rothfuchs A, Goncalves R, Roffe E, Cheever AW, et al. (2010) Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest 120: 1674-1682.
46. Mutoloki S, Cooper GA, Marjara IS, Koop BF, Evensen O (2010) High gene expression of inflammatory markers and IL-17A correlates with severity of injection site reactions of Atlantic salmon vaccinated with oil-adjuvanted vaccines. BMC Genomics 11: 336.
47. Merchant S, Korbelik M (2013) Upregulation of genes for C-reactive protein and related pentraxin/complement proteins in photodynamic therapy-treated human tumor cells: enrolment of PI3K/Akt and AP-1. Immunobiology 218: 869-874.